← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 7, 2020Last known activity
Mar 25, 2024
Timeline
2010s
- Jun 1, 2017
NeuroBo Pharmaceuticals— Founded
- Jul 26, 2019
Gemphire Therapeutics, Inc.— Acquired
Drugs by trial phase (7 distinct, 15 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 2 via acquisition)
Phase 1 (1 own, 1 via acquisition)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (7)
- NCT06252220Lead sponsorPhase 1Mar 25, 2024
- NCT06054815Lead sponsorPhase 2Sep 14, 2023
- NCT04705415Lead sponsorPhase 1Nov 17, 2020
- NCT04705415Study directorPhase 1Nov 17, 2020
- NCT04603924Study directorPhase 2/Phase 3Oct 7, 2020
- NCT04603924Lead sponsorPhase 2/Phase 3Oct 7, 2020
- NCT04603924Study directorPhase 2/Phase 3Oct 7, 2020
Details
- Founded
- Boston, MA, US Jun 1, 2017
- Last known activity
- Mar 25, 2024